ASX:IPD News | QuoteStream

quartr

IPD: Q4 FY26 delivered revenue growth, expanded reimbursement, and strong cash position

Q4 FY26 saw revenue of $3.6m, ARR of $14.4m, and a cash balance of $15.3m after a capital raise. SOZO platform expansion continued in cancer survivorship, heart failure, and weight management, with 95% US reimbursement coverage and strong patient test growth.Original document: Impedimed Limited [IP…

Quartr en_IN 28/7/2026, 06:56 am GMT+8

StocksAU

IPD

quartr

IPD: Q4 FY26 delivered revenue growth, strong cash position, and expanded reimbursement coverage

Q4 FY26 saw revenue of $3.6m, ARR of $14.4m, and a cash balance of $15.3m, supported by a capital raise. SOZO unit sales grew in the U.S., reimbursement coverage reached 95%, and the company is targeting cost reductions and expansion in key healthcare segments.Original document: Impedimed Limited…

Quartr en_IN 28/7/2026, 06:55 am GMT+8

StocksAU